POLG and Parkinson disease: In support of this concept, a reduced mtDNA copy number and an increase in the mutational burden of mtDNA, are potential biomarkers of PD as patients harboring mutations in mitochondrial DNA polymerase (POLG) reported to show Levodopa-responsive PD symptoms.